Evidence review
EGCG concentration
Weiss and Anderton (2003) directly compared catechin content across tea preparations using micellar electrokinetic chromatography [3]. Matcha contained approximately 137 mg of EGCG per gram of tea, compared to roughly 63 mg/g for a popular brand of brewed green tea. On a per-serving basis (1-2 g of matcha vs. 2-3 g of loose-leaf tea steeped), this translates to approximately three times the EGCG delivery. The authors attributed this to both the whole-leaf consumption model and the specific cultivars used for matcha production.
L-theanine mechanisms
Hidese et al. (2019) conducted a randomized, placebo-controlled, crossover, double-blind trial examining L-theanine's effects on stress and cognition in 30 healthy adults [4]. Participants receiving 200 mg/day of L-theanine for four weeks showed significant reductions in stress-related symptom scores (STAI state anxiety subscale) and improved performance on attention-related cognitive tasks. The dose used (200 mg) is roughly equivalent to the L-theanine content in 2-3 servings of ceremonial-grade matcha.
Neuroimaging and EEG studies reviewed by Hidese et al. (2019) confirmed that L-theanine increases alpha-wave activity in the brain within 30-40 minutes of ingestion, without causing sedation [1]. This distinguishes L-theanine from other anxiolytics and explains the subjective experience of "relaxed focus" reported by matcha drinkers.
Compositional analysis
Kochman et al. (2021) provided a comprehensive review of matcha's chemical composition [2]. Key findings include:
- Caffeine: matcha contains approximately 18.9-44.4 mg/g, yielding 35-70 mg per typical serving. This is less than a standard cup of coffee but delivered alongside L-theanine, which modulates the stimulant effect.
- Chlorophyll and carotenoids: the shading process increases chlorophyll content, giving matcha its vivid green color. Chlorophyll has been associated with detoxification support, though human evidence for this specific claim is limited.
- Amino acid profile: beyond L-theanine, matcha contains elevated levels of glutamate and arginine compared to non-shaded teas.
Limitations
Most matcha-specific clinical trials are small (n < 50). Much of the health evidence for matcha is extrapolated from the larger green tea literature and the assumption that higher catechin and L-theanine doses translate to proportionally greater effects. Dose-response relationships for whole-leaf tea powder remain under-studied. Heavy metal contamination (particularly lead, which tea leaves can accumulate) is a concern with whole-leaf consumption; sourcing from reputable producers who test for contaminants is advisable [2].